The 55-kDa gene product from subgroup C adenovirus type 5 (Ad5) early region 1 (E1B-55kDa) plays a central role in the oncogenic transformation of primary rodent cells primarily by inactivating transcriptional and presumably other functional properties of the tumor suppressor protein p53. We have previously shown that Ad5 E1B-55kDa possesses a leucine-rich nuclear export signal (NES), which confers rapid nucleocytoplasmic shuttling via the CRM1-dependent export pathway. In this study we report that an export-deficient mutant of the viral protein (E1B-NES) substantially enhances focus formation of primary baby rat kidney cells in combination with Ad E1A. Transformed rat cells stably expressing the E1B-NES protein exhibited increased tumorigenicity and accelerated tumor growth in nude mice compared to transformants containing the wild-type E1B product. This 'gain of function' correlated with enhanced inhibition of p53 transactivation in transient reporter assays and the accumulation of the mutant protein and p53 in several dotlike subnuclear aggregates. Interestingly, these structures also contained a large fraction of cellular promyelocytic leukemia protein (PML), a known regulator of p53. These data indicate that E1B-NES promotes oncogenic transformation by combinatorial mechanisms that involve modulation of p53 in the context of PML nuclear bodies. In sum, these results extend our previous observation that inhibition of PML activities by E1B-55kDa is required for efficient focus formation and provide further support for the view that blocking p53 transcriptional functions is the principal mechanism by which the Ad protein contributes to complete cell transformation in conjunction with Ad E1A.
Introduction
The 55-kDa product from adenovirus type 5 (Ad5) early region 1B (E1B-55kDa) belongs to a group of adenoviral regulatory proteins that are individually capable of cooperating with Ad early region 1A (E1A) to oncogenically transform primary rodent cells in culture (for review, see Endter and Dobner, 2004) . Over the past years, it has been generally accepted that E1B-55kDa contributes to complete cell transformation, at least in part, by counteracting programmed cell death (Sabbatini et al., 1995; Teodoro and Branton, 1997) and cell cycle arrest (Yew and Berk, 1992; Hutton et al., 2000) , which primarily result from the induction and metabolic stabilization of p53 by Ad E1A (Debbas and White, 1993; Lowe and Ruley, 1993 ). It appears that these activities are intimately linked to the ability of the Ad5 protein to bind to the amino-terminal region of p53 (Sarnow et al., 1982a; Lin et al., 1994) and to block activation of p53-responsive promoters via an intrinsic transcriptional repression domain (Yew and Berk, 1992; Teodoro et al., 1994; Yew et al., 1994; Martin and Berk, 1998; Endter et al., 2001 ; Figure 1A ). As understood, at present the silencing activity of 55-kDa protein involves interactions with a variety of cellular factors implicated in transcriptional control (Martin and Berk, 1999; Liu et al., 2000; Punga and Akusja¨rvi, 2000; and is regulated by phosphorylation at residues in the repression domain (Teodoro et al., 1994; Teodoro and Branton, 1997) . Furthermore, it has been shown that efficient inhibition of p53-mediated transactivation by Ad5 E1B-55kDa is dependent on SUMO1 conjugation, which is apparently required for efficient nuclear import of the viral protein in transformed baby rat kidney (BRK) cells (Endter et al., 2001) .
Prior work has suggested also that the Ad5 protein may negatively regulate transcriptional and other functional properties of p53 during the transformation process by altering its steady-state localization in transformed cells. Evidence for this idea originates from the observation that E1B-55kDa products from subgroup C viruses Ad2 and Ad5 (Ad2/5) accumulate with a large fraction of cellular p53 mostly in a single cytoplasmic body in transformed rodent cells (Zantema et al., 1985a, b; Blair-Zajdel and Blair, 1988 ). This spherical phase-dense structure frequently includes centrosomal proteins (Blair-Zajdel and Blair, 1988; Brown et al., 1994) , and also contains microfilaments, hsp70 as well as the tumor suppressor protein WT1 (Zantema et al., 1985a; Brown et al., 1994; Maheswaran et al., 1998) . A certain amount of data indicates that formation of the cytoplasmic body is specified by the Ad2/5 E1B-55kDa products (Zantema et al., 1985b; Goodrum et al., 1996; Ko¨nig et al., 1999; Wienzek et al., 2000) , and requires stable complex formation with the tumor suppressor protein (Zantema et al., 1985a; van den Heuvel et al., 1992; Hutton et al., 2000) . More recently, it has been shown that disruption of the cytoplasmic body in Ad5 E1A/E1B-transformed cells results in a significant reduction in cell growth, which correlates with the translocation of transcriptionally active p53 to the nucleus (Grand et al., 1999) . In addition, Liao and co-workers demonstrated that cytoplasmic sequestration of p53 by the large E1B protein from subgroup A Ad12 (E1B-54kDa) inhibits p53-mediated apoptosis in transiently transfected Saos2 cells most likely by blocking the import of p53 into mitochondria . Therefore, it appears that deposition of p53 in cytoplasmic aggregates may play a role in the E1B-mediated inhibition of p53-induced cell cycle arrest and apoptosis (Hutton et al., 2000; .
The molecular basis underlying the cytoplasmic restriction imposed on p53 is still unknown. Recent work, however, has shown that Ad5 E1B-55kDa possesses an intrinsic nucleocytoplasmic shuttling activity, which is independent of p53 and Mdm2 (Kra¨tzer et al., 2000; Dosch et al., 2001) . Genetic and biochemical data demonstrated that nuclear export of Ad5 E1B-55kDa is mediated via the cellular export receptor CRM1 and requires a leucine-rich nuclear export signal (NES) present in the amino-terminal portion of this viral protein (Kra¨tzer et al., 2000; Dosch et al., 2001; Endter et al., 2001 ; Figure 1A ). These findings raise the intriguing possibility that the subcellular localization of p53 involves CRM1-dependent nucleocytoplasmic trafficking of the Ad5 E1B-55kDa protein. As a consequence, active nuclear export may be an integral part of the mechanisms by which the viral protein antagonizes antiproliferative activities of p53 and, thus, may be critical to initiate and/or maintain complete cell transformation in combination with Ad E1A. To examine this model, an export-deficient mutant of the Ad5 protein was tested for its ability to transform primary BRK cells in cooperation with Ad E1A and its ability to inhibit p53-mediated transcriptional activation.
Results
The Ad5 E1B-55kDa protein shuttles in rat epithelial cells Previously we have shown that Ad5 E1B-55kDa actively shuttles between the nuclear and cytoplasmic compartments via the CRM1-dependent export pathway in established human and mouse cell lines (Kra¨tzer et al., 2000; Dosch et al., 2001) . Nucleocytoplasmic trafficking is mediated by a leucine-rich NES of the HIV-1 Rev-type and can be blocked by point mutations within the E1B NES or export competitors such as HTLV-1 Rex, as well as the low-molecular-weight CRM1 inhibitor leptomycin B (LMB) (Kra¨tzer et al., 2000; Dosch et al., 2001) . To confirm whether E1B-55kDa exhibits a similar activity in rat epithelial cells, plasmids encoding wild-type E1B-55kDa (pE1B-55K) and a variant (pE1B-NES) containing three single amino-acid changes in the NES ( Figure 1A ) were transfected into BRK1 cells and the localization of both proteins was determined by indirect immunofluorescence. Consistent with previous findings (Goodrum et al., 1996; Ko¨nig et al., 1999; Kra¨tzer et al., 2000; Wienzek et al., 2000) , the wild-type E1B protein was found in the cytoplasm mostly concentrated in cytoplasmic clusters ( Figure 1B , panel a). By contrast, essentially all of the NES mutant protein was restricted to the nucleus where it accumulated in large dot-like aggregates ( Figure 1B, panel b) . A similar variation in the steady-state localization of the viral protein was observed in pE1B-55K-transfected BRK1 cells after treatment with LMB ( Figure 1B , panel c) or in the presence of the HTLV-1 Rex-p21 protein ( Figure 1B , panel d), previously shown to efficiently block the nuclear export of the Ad5 protein (Kra¨tzer et al., 2000) . These results demonstrate that Ad5 E1B-55kDa continuously shuttles in BRK cells via the CRM1-dependent export pathway and that this activity is mediated through its leucine-rich NES.
Ad5 E1B-55kDa lacking an intact NES augments transformation of primary BRK cells and inhibition of p53 transactivation Inactivation of p53 transcriptional functions is an integral part of the molecular mechanisms used by the Ad5 E1B-55kDa protein to contribute to complete transformation of primary rat cells (Yew et al., 1990 (Yew et al., , 1994 Teodoro et al., 1994; Endter et al., 2001) . As understood at present, these activities involve binding to p53, blocking p53-mediated transcription through an intrinsic repression function and presumably depletion of p53 from the nucleus via the CRM1-dependent nuclear export pathway. To reveal the importance of the latter process in the ability of the Ad5 protein to promote cell transformation, we transfected primary BRK cells with plasmids expressing the E1A gene (pE1A) in combination with either wild-type E1B-55kDa (pE1B-55K), the NES-deficient E1B (pE1B-NES) or the previously described mutant E1B-K104R (pE1B-K104R), which contains a single mutation (K104R) in the principal SUMO1 attachment site of the 55-kDa product. This protein binds to p53 with wild-type affinity, but is defective in SUMOylation in vivo, efficient nuclear accumulation, blocking p53 transcriptional activation and transformation (Endter et al., 2001) . Cotransfection of pE1A with increasing amounts of plasmid pE1B-55K resulted in a five-to sevenfold increase in foci compared with E1A alone, whereas the E1B-K104R mutant was completely inactive for cooperative focus formation (Figure 2) . Surprisingly, no reduction in focus formation was seen when the E1B-NES mutant was coexpressed with E1A. Instead, on average there was a dose-dependent increase of 20-40% in the number of foci relative to the wild-type 55-kDa product.
A comparable result was obtained when we tested the E1B-NES mutant for its ability to inhibit p53-dependent activation of a luciferase reporter containing five p53-binding sites (pRE-LUC) in p53-negative human H1299 cells (Figure 3a) . It appeared that the E1B-NES mutant reproducibly repressed p53-mediated induction of the reporter more efficiently than the wild-type protein in a concentration-dependent manner. On the contrary, no substantial reduction in luciferase activity was seen in control experiments employing the E1B-K104R mutant. The location of the NES sequence is represented by a gray box. Numbers refer to amino-acid residues, and number 496 denotes the last amino acid. Bottom: The amino-acid sequence of the NES (residues 83-93) in the wild-type protein (WT) and a variant (NES*) with alanine substitutions at positions 83, 87 and 91. The leucine residues known to be critical for export function (Kra¨tzer et al., 2000) are shown in bold. (B) Nucleocytoplasmic trafficking of Ad5 E1B-55kDa in BRK1 cells is dependent on the NES. Subconfluent BRK1 cells were transfected with the appropriate cDNA under the control of the CMV promoter to express the wild-type E1B-55kDa protein (a and c), the E1B-NES mutant protein (b) or wild-type E1B-55kDa plus the HTLV-1 Rex protein (d). The Ad protein was visualized with anti-E1B-55kDa mouse MAb 2A6 at 36 h post-transfection, and representative cells are shown (a-d). To reveal the effect of LMB on the subcellular localization of the wild-type E1B-55kDa protein, transfected cells were treated with 10 nM of the cytotoxin 3 h prior to fixation (c). Magnification Â 7600 CRM1-mediated nuclear export of Ad5 E1B-55kDa C Endter et al To determine whether these results are due to differences in expression of wild-type and mutant proteins, we analysed extracts from transfected H1299 cells by immunoblotting ( Figure 3b ). The results from these experiments show that all transfected plasmids express stable proteins at similar levels. Taken together, these data demonstrate that Ad5 E1B-55kDa lacking an intact NES augments both focal transformation of primary BRK cells in combination with Ad E1A and inhibition of p53-mediated transactivation. Consequently, active nuclear export of E1B-55kDa via the CRM1-dependent pathway is neither required for cooperative focus formation nor for efficient repression of transcriptional activation by p53.
Abrogation of nuclear export of Ad5 E1B-55kDa alters the subcellular distribution of p53
In light of these unexpected observations, we next tested the effect of the NES mutations on the subcellular distribution of E1B-55kDa and p53 in stably transformed BRK cells. Following selection with G418, two different pools of foci from cultures transfected with pE1A and pE1B-NES (AB18 and AB115 cells) were generated. These were compared by double-label immunofluorescence to the previously described AB120 cells coexpressing the Ad5 wild-type E1A and E1B-55kDa products (Endter et al., 2001) . Representative samples of these analyses are shown in Figure 4 . Consistent with previous findings, most E1B-55kDa present in AB120 cells was restricted to the cytoplasm and concentrated in a large spherical perinuclear body that also included nearly all of cellular p53 ( Figure 4 , panels a-c). By contrast, a different pattern of localization was observed for both proteins in AB18 and AB115 cells ( Figure 4 , panels d-i). All of these cells examined (n>100) exhibited a greatly reduced amount of diffuse cytoplasmic staining for the Ad protein. However, a large portion of the NES mutant appeared to be evenly distributed throughout the nucleoplasm (Figure 4 , panels d and g), and some of this protein colocalized with p53 in several brightly stained nuclear foci (Figure 4 , panels e, f, h and i) that resembled the subnuclear condensations seen in pE1B-NES-transfected BRK1 cells ( Figure 1B, panel b) . In addition to this characteristic nuclear staining pattern, most AB18 and 115 cells (>90%) also contained E1B/p53-positive cytoplasmic clusters, which typically exhibited elongated, filamentous structures.
The apparent variations in the staining pattern between wild-type E1B-55kDa and the NES mutant protein clearly show that the viral protein actively shuttles via the CRM1-dependent export pathway in E1A/E1B-transformed cells and demonstrate that mutations in its NES interfere with the export activity of essentially all E1B molecules typically seen homogenously distributed in the cytoplasm of BRK transformants expressing the wild-type E1B product. On the other hand, the high percentage of AB18 and AB115 cells showing E1B/p53-positive cytoplasmic clusters suggests that the accumulation of the Ad protein and p53 in cytoplasmic bodies is largely unaffected by the NES mutations, indicating that cytoplasmic deposition of p53 may occur independently from CRM1-dependent export of the Ad protein. In support of this, treatment of AB120 cells with LMB ( Figure 4 , panels j-l) had no effect on the formation of cytoplasmic bodies, although all of these cells demonstrated a similar nuclear staining pattern for both proteins as observed in AB18 and AB115 cells.
Inhibition of CRM1-dependent nuclear export of Ad5 E1B-55kDa in transformed BRK cells relocalizes PML to E1B/p53-containing nuclear bodies Prior work has demonstrated that Ad5 E1B-55kDa colocalizes with dot-like nuclear substructures known as nuclear domain 10 (ND10) or promyelocytic leukemia nuclear bodies (PML-NBs) in Ad-infected cells (Doucas et al., 1996) . PML-NBs comprise multiprotein nuclear complexes closely attached to the nuclear matrix and have been associated with various aspects of cell growth control, including p53-mediated apoptosis (reviewed in CRM1-mediated nuclear export of Ad5 E1B-55kDa C Endter et al Borden, 2002; Bernardi and Pandolfi, 2003) . Also, more recent studies have shown that the PML-NB-associated PML protein physically interacts with p53 and regulates p53 tumor suppressor function, which seems to depend on the localization of both proteins in PML-NBs (Fogal et al., 2000; Guo et al., 2000; Pearson et al., 2000) . We therefore wondered whether the E1B-NES/p53-positive nuclear foci observed in AB18 and AB115 cells may correspond to PML-NBs. To test this possibility, the localization of wild-type E1B-55kDa, the E1B-NES mutant, p53 and PML was determined in the established cell lines by double-label immunofluorescence ( Figure 5 ). As before, in AB120 cells, E1B-55kDa was mostly excluded from the nucleus and seen predominantly concentrated in a perinuclear body, while the PML protein exhibited a punctate and nuclear fluorescence characteristic for the PML-NBs ( Figure 5 , panels a and b). By contrast, immunofluorescence staining of PML in AB18 (not shown) and AB115 cells (n>100) revealed a variable number of large nuclear condensations, which invariably coincided with the subnuclear structures containing the E1B-NES mutant protein ( Figure 5 , panels d-f) and p53 ( Figure 5 , panels g-i). Significantly, no subnuclear p53/PML-positive foci were observed in AB120 cells ( Figure 5 , panels j-l), or primary BRK cells grown in the presence ( Figure 5 , panels m-o) or absence ( Figure 5 , panels p-r) of LMB. Thus, it appears that the NES mutations induce the redistribution of PML-NBassociated factors, such as PML, into discrete subnuclear compartments. Whether this process also involves other PML-NB components or the whole PML-NB complex remains to be seen. In summary, these findings together with the data presented above demonstrate that inhibition of CRM1-dependent nuclear export of E1B-55kDa by mutational inactivation of its NES results in the nuclear accumulation of a large fraction of the Ad protein and the formation of nuclear aggregates containing p53, PML and E1B-55kDa. Accordingly, it seems very likely that augmentation of focal transformation and inhibition of p53 transactivation by the NES mutant is intimately linked to the ability of the mutant protein to sequester p53 together with PML in distinct nuclear aggregates.
Ad5 E1B-55kDa lacking an intact NES enhances the tumorigenicity of transformed BRK cells in nude mice
Several studies have shown that the large E1B proteins from subgroups A and C viruses provide functions that elevate the tumorigenic phenotype of the transformed cell (Bernards et al., 1982 (Bernards et al., , 1983 Sawada et al., 1988) . In this context, it has been reported that Ad5 E1A/E1B-transformed 3Y1 rat cells containing low steady-state levels of E1B-55kDa form tumors in nude mice more rapidly than cells with high levels of the Ad protein (van den Heuvel et al., 1990) . A certain amount of data suggests that the reduced tumorigenicity associated with high expression levels of the viral protein correlates with the depletion of p53 from the nucleus through stable complex formation with E1B-55kDa and subsequent formation of cytoplasmic bodies (van den Heuvel et al., 1990). On the basis of these findings, it has been proposed that the Ad5 E1B-dependent cytoplasmic sequestration of p53 reduces the intrinsic ability of these cells to grow in a neoplastic state in vivo. In light of these observations, we therefore asked whether the increase of nuclear p53 and E1B-55kDa observed in AB18 and AB115 cells affects the oncogenicity of these cells in athymic nude mice (Table 1) . Tumor induction was compared to AB120 and AB19 cells expressing the wild-type E1B-55kDa and the E1B-K104R mutant protein, respectively (Endter et al., 2001) . Additionally CRM1-mediated nuclear export of Ad5 E1B-55kDa C Endter et al we monitored tumor growth of ABS1 cells previously shown to induce rapidly growing and highly malignant tumors in nude mice (Nevels et al., 1999a, b; . This cell line expresses the entire Ad5 E1 region (E1A and E1B) plus the Ad5 E4orf6 protein (Nevels et al., 1997) . During a 67-day observation period all of the animals receiving 1 Â 10 6 AB18, AB115 and ABS1 cells developed visually apparent tumors and as early as 12 days after injection, whereas no tumors were induced by AB19 cells during the observation period. One small tumor was also observed with AB120 cells but only after an extended delay of 40 days. Consistent with our previous data, tumors induced by ABS1 cells grew rapidly and reached tumor sizes of approximately 130 mm 2 already at 33 days after injection. Significantly smaller tumors (12 mm 2 ) were obtained with AB18 and AB115 cells after the same incubation period, although they finally reached tumor sizes of about 71 and 206 mm 2 , respectively, at 67 days after injection. To determine whether a change in distribution and expression levels of the E1B and p53 proteins had occurred during the in vivo growth, we performed indirect immunofluorescence and immunoblot analyses with cells derived from AB115-and AB120-induced tumors and the parental cell lines ( Figure 6 ). As in the parental cell lines, the E1B-NES mutant protein and p53 exhibited a dominant nuclear and cytoplasmic dot-like staining ( Figure 6A , panels a and b), while the majority of the wild-type protein and p53 were mostly found concentrated in large cytoplasmic bodies ( Figure 6A , panels c and d). Also, when assayed by immunoblotting, no significant change in expression levels of E1B-55kDa, E1A and p53 proteins had occurred in tumor-derived cells ( Figure 6B , lanes 2 and 3) compared to the parental cell lines ( Figure 6B , lanes 5 and 6). Taken together, these in vivo studies show that Ad5 E1B-55kDa lacking an intact NES substantially increases the tumorigenicity of E1A/E1B-transformed BRK cells in nude mice and suggest that this effect is related to the observed redistribution of p53 and PML to distinct subnuclear foci.
Discussion
In this report, we have examined the role of CRM1-mediated nucleocytoplasmic export of Ad5 E1B-55kDa in E1A/E1B-mediated transformation of primary BRK cells. Our results show that an export-deficient mutant of the viral protein (Figure 1 ) substantially enhances c Tumor areas were measured at 67 days after inoculation as the product of two perpendicular diameters, one measured across the greatest width of the tumor. CRM1-mediated nuclear export of Ad5 E1B-55kDa C Endter et al focus formation of primary BRK cells compared to the wild-type product (Figure 2 ). This 'gain of function' correlates with enhanced inhibition of p53-mediated transcription in transient reporter assays (Figure 3) . Consequently, CRM1-dependent nuclear export of the Ad5 protein is neither required for cooperative focus formation in combination with Ad E1A nor for inhibition of p53 transactivation. Rather, it appears that this intrinsic activity of the wild-type protein exerts a negative effect on both processes. These results are unexpected and contrast the model that depletion of nuclear p53 through E1B-mediated active nucleocytoplasmic shuttling may play an important role in the inactivation of p53 and consequently complete cell transformation.
Over the past few years, it has been well established that PML is an important mediator of p53-induced apoptosis and growth arrest (reviewed in Hofmann and Will, 2003) . Considerable evidence suggests that these activities involve binding to p53 and depend on the localization of both proteins in PML-NBs. Given the importance of PML and PML-NBs in the regulation of p53 tumor suppressor function, we find it intriguing that the E1B-NES mutant causes the formation of several distinct nuclear aggregates containing p53 and PML ( Figure 5 ). In fact, at the level of resolution afforded by indirect immunofluorescence microscopy, it appeared that nearly all of p53 and PML present in the nuclei of AB18 and AB115 cells were recruited to a few distinct aggregates, which invariably coincided with the subnuclear foci containing the E1B-NES mutant (Figures 4 and 5) . These findings raise the possibility that the enhancing effects of the mutant protein on focus formation, inhibition of p53 transactivation and tumor growth may be ultimately linked to the apparent redistribution of PML and p53 from their transcriptionally active sites into presumably transcriptional inactive PML-NBs (Wang et al., 2004) . Consistent with this idea, it has been shown that E1B-55kDa from Ad2 directly interacts with the PML-NB component Daxx and colocalizes with p53 and Daxx in discrete nuclear dots, which are distinct from PML-NBs . These findings along with the results presented in this report strongly suggest that the transforming potential of Ad2/5 E1B-55kDa proteins involves the modulation of p53 plus PML in the context of PML-NBs and possibly other PML-NB components. Consequently, mutations in the E1B NES could potentially augment these processes by increasing the amount of nuclear E1B-55kDa, thereby enhancing transformation frequency in cooperation with Ad E1A oncogenes.
Assuming that high levels of nuclear E1B-55kDa more efficiently inactivate p53 and PML tumor suppressor functions, it seems likely that the observed differences in oncogenicity between AB120 and AB18/ 115 cells are also linked to the NES mutant protein's inability to shuttle between the nuclear and cytoplasmic compartments. Such a model would fit well with the observation that no selection against nuclear E1B/p53-containing aggregates had occurred during tumor growth ( Figure 6 ) and our previous findings that transformed rat cells expressing Ad5 E4orf3 and/or E4orf6 in addition to E1A plus E1B exhibit increased oncogenicity in nude mice (Nevels et al., 1999a, b) : both E4 proteins negatively regulate nuclear export of the large E1B protein (Goodrum et al., 1996; Moore et al., 1996; Ko¨nig et al., 1999; Leppard and Everett, 1999; Lethbridge et al., 2003) . Consistent with this idea is the previous finding that E1B-54kDa from the highly oncogenic subgroup A Ad12 provides functions that enhance tumorigenicity of Ad5 E1A/E1B-transformed cells in nude mice when substituted for the Ad5 E1B protein (Bernards and van der Eb, 1984) . Significantly, E1B-54kDa exhibits a predominant nuclear localization in Ad12-transformed cells, which is probably due to the lack of a functional NES in the Ad12 polypeptide (Kra¨tzer et al., 2000) . Thus, it is tempting to speculate that NES-mediated continuous nuclear export of Ad5 E1B-55kDa may play a negative role in determining the oncogenicity of Ad5 E1A/E1B-transformed cells.
Although E1B/p53-containing cytoplasmic bodies are a characteristic feature of subgroup C Ad2/5-transformed cells, their role in cell transformation is still unknown. Several studies employing a series of Ad2/5 mutants indicate that there is no strict correlation between the ability of the Ad2/5 E1B-55kDa proteins to sequester p53 in cytoplasmic complexes and their ability to transform primary rat cells in cooperation with Ad E1A oncogenes (Yew and Berk, 1992; Teodoro et al., 1994; Yew et al., 1994; Martin and Berk, 1998; Endter et al., 2001) . In support of this, it has been shown that Ad12 E1B-54kDa also inhibits transcriptional activation of p53 (Yew and Berk, 1992; even though the Ad12 product does not sequester p53 in cytoplasmic complexes in Ad12 transformed rodent cells (Zantema et al., 1985b) . It should be noted, however, that in some Ad12 transformants E1B-54kDa locates to the cytoplasm (Mak et al., 1988; Grand et al., 1993) . Moreover, it has been shown recently that overexpression of p53 and Ad12 E1B-54kDa in p53-negative human cells causes the accumulation of E1B/ p53-containing bodies in the cytoplasm (Wienzek et al., 2000; , which correlates with suppression of p53-mediated apoptosis by Ad12 E1B-54kDa most likely by blocking the import of p53 into mitochondria . At present, it is disputed whether formation of p53/E1B-55kDa-containing cytoplasmic complexes requires CRM1-mediated nuclear export of the Ad protein. Our data clearly suggest that this activity is not critical for the cytoplasmic deposition of the tumor suppressor, since most AB18 and AB115 cells contained these structures, which also remained evident in AB120 cells (Figure 4 ) and AB18/155 cells (data not shown), which were grown in the presence of the CRM1 nuclear export inhibitor LMB. An explanation for these observations could be that the cytoplasmic accumulation of these overexpressed proteins may reflect the recruitment of surplus proteins to distinct cytoplasmic storage sites immediately after translation where they are inaccessible to cellular components of the nuclear import machinery.
CRM1-mediated nuclear export of Ad5 E1B-55kDa C Endter et al Such a model is compatible with earlier findings, indicating that these cytoplasmic structures may represent insoluble protein aggregates presumably formed in response to high expression levels of the viral protein in Ad2/5 transformants (Zantema et al., 1985a; BlairZajdel and Blair, 1988; van den Heuvel et al., 1990) .
In summary, we have demonstrated that inhibition of CRM1-mediated export of Ad5 E1B-55kDa augments oncogenic transformation of primary BRK cells. This 'gain of function' involves combinatorial effects that modulate p53 and presumably PML tumor suppressor function. These results extend our previous observation that inhibition of PML activities by E1B-55kDa is required for efficient focus formation (Nevels et al., 1999b; Endter et al., 2001) and provide further support for the view that blocking p53 transcriptional functions is the principal mechanism by which the Ad protein contributes to complete cell transformation in conjunction with Ad E1A.
Materials and methods

Plasmids
The plasmids containing the Ad5 E1A (pE1A) and wild-type E1B-55kDa (pE1B-55K) genes have been described previously (Endter et al., 2001; Nevels et al., 2001) . pE1B-NES and pE1B-K104R express the Ad5 E1B-55kDa NES and K104R mutant proteins, respectively, under the control of the cytomegalovirus (CMV) major immediate-early promoter from vector pcDNA3 (Invitrogen). pE1B-K104R contains a single aminoacid change at position 104 (lysine to arginine) (Endter et al., 2001) , and pE1B-NES carries three single amino-acid changes at positions 83, 87 and 91 (leucine to alanine) that were introduced into pE1B-55K by using the QuickChange SiteDirected Mutagenesis Kit (Stratagene) with synthetic oligonucleotide primers #594 5 0 -GTGGCTGAAGCGTATCCA-GAAGCGAGACGCATTGCGACAATTACA-3 0 and #595 5 0 -TGTAATTGTCGCAATGCGTCTCGCTTCTGGA-TACGCTTCAGCCAC-3 0 . The mutations were confirmed by DNA sequencing. Plasmid pC53-SN3 encodes human wildtype p53 from the pCMV/neo vector. The firefly luciferase reporter plasmid pRE-LUC contains five p53-binding sites upstream of a minimal CMV promoter (Endter et al., 2001) . pF143Rexp21, which expresses the HTLV-1 Rex-p21 protein, was a generous gift from Roland Stauber (Paul-EhrlichInstitut, Frankfurt/Main, Germany).
Transformation assays and cell lines
Primary BRK cells were obtained from kidneys of 5-to 6-dayold Sprague-Dawley rats as described previously (Nevels et al., 1997 (Nevels et al., , 1999b . They were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). For transformation assays, subconfluent BRK cells were transfected by calcium phosphate precipitation (Graham and van der Eb, 1973) with the indicated plasmid amounts (see Figure 2) . At 3-4 weeks after transfection, foci were stained with crystal violet (1% in 25% methanol) and dense foci of morphologically transformed cells were counted. Alternatively, foci were pooled and expanded into permanent cell lines.
The transformed BRK cell lines AB120 and AB19 have been described previously (Nevels et al., 1999a, b; Endter et al., 2001 ). AB120 cells express the Ad5 E1A and E1B-55kDa proteins. The cell line AB19 was established from foci obtained by cotransfection of pE1A and pE1B-K104R (Endter et al., 2001) . AB18 and AB115 cells are G418-selected cell lines of polyclonal origin derived from transfection of primary BRK cells with pE1A and pE1B-NES. The cell line BRK1 was established from a spontaneously immortalized rat cell foci (unpublished results). With the exception of AB18, AB19 and AB115 cells, all BRK cell lines and the p53-negative human cell line H1299 (Mitsudomi et al., 1992) were grown in DMEM with 10% FCS. For AB18, AB19 and AB115 cells, the same medium plus 500 mg of G418 (Calbiochem) per ml was used.
To analyse the subcellular localization of proteins in tumor tissues, the tumors were removed and incubated with 1 mg/ml dispase-collagenase (Boehringer Mannheim) at 371C for 3-4 h. The single-cell suspension was then seeded on tissue culture dishes and expanded in DMEM containing 10% FCS and 500 mg/ml G418.
Transient transfections
For dual luciferase assays, subconfluent H1299 cells were transfected by the calcium phosphate co-precipitation procedure (Graham and van der Eb, 1973) using the indicated amounts of reporter and effector plasmids (see Figure 3 ) and 0.25 mg of pRL-TK (Promega), which expresses the Renilla luciferase under the control of the herpes simplex virus thymidine kinase (HSV-TK) promoter. Total cell extracts were prepared 36 h after transfection in lysis buffer and RGC firefly luciferase activity was assayed with 20 ml of extract in an automated luminometer (Lumat LB9510, Berthold). All samples were normalized for transfection efficiency by measuring Renilla luciferase activity.
For indirect immunofluorescence analyses, subconfluent BRK1 cells seeded on glass coverslips were transfected with 1 mg of pE1B-55K or 5 mg of pF143Rexp21 by calcium phosphate precipitation. At 48 h post-transfection, coverslips were washed three times in phosphate-buffered saline (PBS) and cells were fixed as described below.
Antibodies, indirect immunofluorescence and immunoblotting
The following monoclonal antibodies (MAbs) were used in this study: the mouse MAbs 2A6, M73 and 5E10 are specific for Ad5 E1B-55kDa (Sarnow et al., 1982b) , Ad E1A (Harlow et al., 1985) and PML, respectively. The rat MAb 9C10 is specific for Ad5 E1B-55kDa. MAb 5E10 was kindly provided by Luitzen de Jong (University of Amsterdam, The Netherlands) and 9C10 was a generous gift of Alt Zantema (Leiden University, The Netherlands). The mouse MAb 421 reacts with p53 proteins from different species, including rats (Harlow et al., 1981) , and the mouse MAb AC-15 (Sigma) reacts with b-actin. The polyclonal rabbit antibody FL393 was obtained from Santa Cruz and is specific for the p53 protein.
For indirect immunofluorescence analyses, transformed BRK cell lines were grown on glass coverslips to subconfluent densities. For LMB treatment, cells were incubated for 3 h in medium containing 10 nM LMB before fixation. Coverslips were washed three times in PBS and cells were fixed with paraformaldehyde (2% in PBS) for 10 min at room temperature and permeabilized in PBS-containing 0.5% (vol/vol) Triton X-100 (Sigma). Indirect immunofluorescence was conducted as previously described (Endter et al., 2001) . For double-label immunofluorescence, cells were reacted for 1 h with the corresponding MAbs followed by 1 h incubation with the appropriate fluorescein isothiocyanate-(FITC) or Texas Red-conjugated secondary antibodies (Dianova). Coverslips were then mounted in Glow medium (Energene). Digital images were acquired on a DMRB fluorescence microscope (Leica) with a charge-coupled device camera (Diagnostic Instruments). They were cropped using Photoshop 7.0 (Adobe Systems) and assembled with Illustrator 10.0 (Adobe Systems) on a Macintosh microcomputer.
For analysis of protein expression by Western blotting, cells were lysed in radioimmunoprecipitation buffer (50 mM Trischloride (pH 8.0), 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride, 0.3 mM aprotinin, 1 mM leupeptin, 1 mM pepstatin). Equal amounts of total protein were separated on SDS-10% polyacrylamide gels and subjected to immunoblotting exactly as previously described (Nevels et al., 2001) .
Tumorigenicity in nude mice
Analyses of tumor growth in NMRI(nu/nu) mice were exactly as described previously (Nevels et al., 1999a, b) . Briefly, transformed cells were harvested by scraping into PBS. Nude mice were injected subcutaneously with 1 Â 10 6 cells in serumfree DMEM and tumor growth was recorded weekly with an electronic caliper.
